As of now the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has enrolled 16,505 participants across a number of certified mammography clinics in the U.S., Canada and Argentina, with more sites and participants to come.

Canadian Nuclear Laboratories and TRIUMF, the country’s particle accelerator center, have successfully produced actinium-225—a rare isotope that can be used for novel cancer therapy treatments.

“Because BI-RADS 3 breast lesions have up to 2% likelihood of malignancy, it is imperative that optimal follow-up of BI-RADS 3 test results be addressed...," authors of the new study published in JACR wrote.

Researchers found that deep convolutional neural networks (CNNs) can predict sequence types for brain MR images, sharing their findings in the Journal of Digital Imaging.

Deep convolutional neural networks (CNNs) can be trained to predict sequence types for brain MR images, according to new research published in the Journal of Digital Imaging.

The researchers analyzed 39 consecutive patients with 44 pathologically confirmed cirrhotic nodules who first received a CEUS exam, followed by a traditional follow-up ultrasound every three or four months for their study.

As part of the collaboration, Yale New Haven Hospital has been using the MRI system for a two-year study involving the American Heart Association. Results of the preliminary research will be announced early next year.

A new startup—Hyperfine—and its visionary leader Jonathan Rothberg are creating a new, portable MRI machine they believe can revolutionize the way doctors think about the technology.